| NORTHWEST BIOTHERAPEUTICS INC (NWBO) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | ||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | ||
| Operating Cash Flow | (14,764,000$) | (13,893,000$) | (6,688,000$) | (9,418,000$) | (20,181,000$) | (8,233,000$) | (16,197,000$) | (12,406,000$) | (16,958,000$) | (13,919,000$) | (11,521,000$) | (11,239,000$) | (8,849,000$) | (16,118,000$) | (14,841,000$) | (12,967,000$) | (11,246,000$) | (7,013,000$) | (6,792,000$) | (13,248,000$) | (10,203,000$) | (8,022,000$) | (6,329,000$) | (7,539,000$) | (5,978,000$) | (6,452,000$) | (9,678,000$) | (9,751,000$) | (14,178,000$) | (4,053,000$) | (11,568,000$) | (4,787,000$) | (14,794,000$) | (3,693,000$) | (12,283,000$) | (14,097,000$) | (17,595,000$) | (22,127,000$) | 11,800,000$ | (27,102,000$) | (17,582,000$) | (18,596,000$) | (8,482,000$) | (16,939,000$) | |||||
| Investing Cash Flow | (905,000$) | (513,000$) | (304,000$) | (93,000$) | (78,000$) | (176,000$) | (521,000$) | (239,000$) | (418,000$) | (437,000$) | (1,249,000$) | (1,333,000$) | (2,160,000$) | (276,000$) | (408,000$) | (58,000$) | (1,553,000$) | (2,691,000$) | (1,507,000$) | (264,000$) | (3,034,000$) | (3,802,000$) | (1,244,000$) | (62,000$) | (114,000$) | (21,000$) | (61,000$) | (164,000$) | 45,402,000$ | 0$ | 0$ | 0$ | 6,000$ | (7,000$) | 218,000$ | (169,000$) | (2,408,000$) | (2,741,000$) | (1,995,000$) | (882,000$) | (1,133,000$) | (11,395,000$) | (21,543,000$) | (3,414,000$) | |||||
| Purchases of Property and Equipment | 905,000$ | 202,000$ | 304,000$ | 93,000$ | 78,000$ | 176,000$ | 239,000$ | 437,000$ | 1,995,000$ | 882,000$ | 1,133,000$ | 0$ | |||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 13,588,000$ | 11,558,000$ | 12,448,000$ | 11,733,000$ | 15,942,000$ | 11,620,000$ | 17,138,000$ | 12,085,000$ | 14,415,000$ | 17,123,000$ | 8,638,000$ | 12,582,000$ | 11,351,000$ | 16,286,000$ | 10,411,000$ | 3,920,000$ | 23,670,000$ | 8,920,000$ | 4,781,000$ | 10,761,000$ | 15,820,000$ | 16,678,000$ | 13,173,000$ | 7,025,000$ | 5,134,000$ | 850,000$ | 29,000$ | 3,939,000$ | (10,821,000$) | 2,065,000$ | 9,865,000$ | 6,762,000$ | 14,295,000$ | 3,851,000$ | 8,048,000$ | 17,488,000$ | 9,244,000$ | 41,661,000$ | 864,000$ | 43,203,000$ | 8,510,000$ | 41,978,000$ | 22,575,000$ | 16,976,000$ | |||||
| End Cash Position | 3,040,000$ | 4,560,000$ | 4,316,000$ | 2,779,000$ | 2,175,000$ | 2,939,000$ | 2,881,000$ | 2,478,000$ | 2,126,000$ | 6,097,000$ | 1,424,000$ | 6,191,000$ | 6,965,000$ | 9,425,000$ | 4,831,000$ | 6,963,000$ | 15,169,000$ | 3,836,000$ | 3,758,000$ | 7,468,000$ | 9,983,000$ | 9,250,000$ | 5,955,000$ | 764,000$ | 372,000$ | 1,970,000$ | 6,676,000$ | 1,970,000$ | 22,224,000$ | 248,000$ | 1,597,000$ | 198,000$ | 117,000$ | 1,051,000$ | 22,000$ | 2,232,000$ | 6,871,000$ | 802,000$ | 2,143,000$ | 11,688,000$ | 21,813,000$ | 5,392,000$ | 19,202,000$ | 3,170,000$ | 13,390,000$ | 1,403,000$ | 8,853,000$ | ||
| Exchange Rate Effect | 561,000$ | 3,092,000$ | (3,919,000$) | (1,618,000$) | 3,553,000$ | (3,153,000$) | (17,000$) | 912,000$ | (1,010,000$) | 1,906,000$ | (635,000$) | (784,000$) | (2,802,000$) | 4,702,000$ | 899,000$ | 462,000$ | 862,000$ | ||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (15,669,000$) | (14,095,000$) | (6,992,000$) | (9,511,000$) | (20,259,000$) | (8,409,000$) | (16,197,000$) | (12,645,000$) | (16,958,000$) | (14,356,000$) | (11,521,000$) | (11,239,000$) | (8,849,000$) | (16,118,000$) | (14,841,000$) | (12,967,000$) | (11,246,000$) | (7,013,000$) | (6,792,000$) | (13,248,000$) | (10,203,000$) | (8,022,000$) | (6,329,000$) | (7,539,000$) | (5,978,000$) | (6,452,000$) | (9,678,000$) | (9,751,000$) | (14,178,000$) | (4,053,000$) | (11,568,000$) | (4,787,000$) | (14,794,000$) | (3,693,000$) | (12,283,000$) | (14,097,000$) | (17,595,000$) | (22,127,000$) | 9,805,000$ | (27,984,000$) | (18,715,000$) | (18,596,000$) | (8,482,000$) | (16,939,000$) | |||||